Lv11
20 积分 2026-02-05 加入
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
1小时前
待确认
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS G12V mutations
10天前
已完结
Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy
3个月前
已完结
Linking p53 immunostaining to TP53 mutation status in patients with non-small cell lung cancer
3个月前
已完结
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
